Product Name:(5-chloro-2-iodophenyl)(2,6-difluorophenyl)methanone

IUPAC Name:(5-chloro-2-iodophenyl)(2,6-difluorophenyl)methanone

CAS:869365-97-9
Molecular Formula:C13H6ClF2IO
Purity:98%
Catalog Number:CM128905
Molecular Weight:378.54

Packing Unit Available Stock Price($) Quantity
CM128905-100mg in stock ƼȌ
CM128905-250mg in stock ȌȌƤ
CM128905-1g in stock ſȱȌ
CM128905-5g in stock ǠƼdž

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:869365-97-9
Molecular Formula:C13H6ClF2IO
Melting Point:-
Smiles Code:FC1=CC=CC(F)=C1C(=O)C1=C(I)C=CC(Cl)=C1
Density:
Catalog Number:CM128905
Molecular Weight:378.54
Boiling Point:433°C at 760 mmHg
MDL No:MFCD10565698
Storage:Keep in dark place, store at 2-8°C.

Column Infos

Alisertib
Puma Biotechnology announced the initiation of its ALISertib in CAncer (ALISCA-Lung1) Phase II trial of alisertib monotherapy for the treatment of patients with extensive stage small cell lung cancer. The ALISCA-Lung1 trial will enroll up to 60 patients with extensive stage small cell lung cancer who have progressed on or after first-line platinum-based chemotherapy and immunotherapy. The primary endpoint of the trial is objective response rate, with secondary endpoints of duration of response, disease control rate, progression-free survival and overall survival. Based upon the outcomes of the study, Puma anticipates meeting with the FDA to explore the potential for an accelerated approval pathway for alisertib in small cell lung cancer. Alisertib is an orally active and selective Aurora A kinase inhibitor, which binds to Aurora A kinase resulting in mitotic spindle abnormalities, mitotic accumulation.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.